Lupin Mgmt on Weak Q3 Number | Co Q3 Nos fall to Rs 221.7 Cr. | CNBC TV18

Lupin Q3 Earnings | Rakesh Jhunjhunwala Quizzes The Management | Power Breakfast | CNBC TV18Подробнее

Lupin Q3 Earnings | Rakesh Jhunjhunwala Quizzes The Management | Power Breakfast | CNBC TV18

Lupin Slumps Post Weak Q1 Performance | Profit Misses Estimates, Margins Contract | #1QWithCNBCTV18Подробнее

Lupin Slumps Post Weak Q1 Performance | Profit Misses Estimates, Margins Contract | #1QWithCNBCTV18

Lupin's Q3 Consolidated Profit Down 72%: Ramesh Swaminathan Tracks Q3FY23 Results Of LupinПодробнее

Lupin's Q3 Consolidated Profit Down 72%: Ramesh Swaminathan Tracks Q3FY23 Results Of Lupin

Earnings With ET NOW | One-Time Expense Hits EBITDA | Lupin Q3Подробнее

Earnings With ET NOW | One-Time Expense Hits EBITDA | Lupin Q3

'Bill Bull' Rakesh Jhunjhunwala Grills Lupin's Mgmt | CNBC TV18Подробнее

'Bill Bull' Rakesh Jhunjhunwala Grills Lupin's Mgmt | CNBC TV18

Nilesh Gupta Of Lupin On Generic Pharma Market | CNBC-TV18Подробнее

Nilesh Gupta Of Lupin On Generic Pharma Market | CNBC-TV18

Budget 2024 | Budget Special: CNBC-TV18 Team Rings NSE Opening Bell | Nirmala Sitharaman | N18SПодробнее

Budget 2024 | Budget Special: CNBC-TV18 Team Rings NSE Opening Bell | Nirmala Sitharaman | N18S

Dabur Reports A Soft Q3 Business Update, Co Expects Flattish Operating Margin In The QuarterПодробнее

Dabur Reports A Soft Q3 Business Update, Co Expects Flattish Operating Margin In The Quarter

Lupin Sees Licensing Income Of Rs 210 Cr In Q3Подробнее

Lupin Sees Licensing Income Of Rs 210 Cr In Q3

Cipla, Lupin Q3 Results Today: Key Things To Watch Out ForПодробнее

Cipla, Lupin Q3 Results Today: Key Things To Watch Out For

Lupin's Management Talks About The Company's Q2FY Results | Halftime Report | CNBC-TV18Подробнее

Lupin's Management Talks About The Company's Q2FY Results | Halftime Report | CNBC-TV18

Lupin Reverses Earlier Gains - CNBC TV18Подробнее

Lupin Reverses Earlier Gains - CNBC TV18

Lupin Posts Net Profit Of ₹130 Crore In Q2: Deven Choksey's Take On Pharma Stocks | CNBC-TV18Подробнее

Lupin Posts Net Profit Of ₹130 Crore In Q2: Deven Choksey's Take On Pharma Stocks | CNBC-TV18

USFDA Warning | Lupin Sees Marginal Impact on Earnings; Resolution to Take 12-15 Mths | CNBC TV18Подробнее

USFDA Warning | Lupin Sees Marginal Impact on Earnings; Resolution to Take 12-15 Mths | CNBC TV18

JSW Plans To Produce A Million Cars By 2030: Sajjan Jindal | Global Leadership SummitПодробнее

JSW Plans To Produce A Million Cars By 2030: Sajjan Jindal | Global Leadership Summit

Have You Updated your Aadhaar? | #shorts | CNBC-TV18Подробнее

Have You Updated your Aadhaar? | #shorts | CNBC-TV18

Decoding Lupin's Q4 Earnings | #4QWithCNBCTV18Подробнее

Decoding Lupin's Q4 Earnings | #4QWithCNBCTV18

Stocks On The Move: Decoding Lupin's Q2FY23 Results | Bazaar Corporate Radar | CNBC-TV18Подробнее

Stocks On The Move: Decoding Lupin's Q2FY23 Results | Bazaar Corporate Radar | CNBC-TV18

Lupin Under Pressure As Brokerages Pessimistic About Margin Guidance | NSE Closing Bell | CNBC-TV18Подробнее

Lupin Under Pressure As Brokerages Pessimistic About Margin Guidance | NSE Closing Bell | CNBC-TV18

YOUR STOCK | Sandeep Wagle On LUPIN Stock & the Need of Looking For a Better Option | CNBC TV18Подробнее

YOUR STOCK | Sandeep Wagle On LUPIN Stock & the Need of Looking For a Better Option | CNBC TV18